ENVB
USDEnveric Biosciences Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$6.100
Haut
$6.645
Bas
$5.520
Volume
0.25M
Fondamentaux de l'Entreprise
Capitalisation Boursière
3.0M
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
0.07M
Bourse
NCM
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Enveric Biosciences Receives FDA Response and Streamlines Plans for EB-003 IND Submission
Enveric expects to file Investigational New Drug application for EB-003 in early 2026 Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or the "Company"), a biotechnology company advancing next-generation neuroplastogenic
Enveric Biosciences to Present at H.C. Wainwright 27th Annual Global Investment Conference
Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or the "Company"), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced that
Enveric Biosciences Relocates Corporate Headquarters to Cambridge, MA
Move aligns with company's vision to leverage the Greater Boston biotech hub's scientific and financial ecosystem and advance EB-003 into first-in-human trial in 2026 Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or
Enveric Biosciences Successfully Completes Pre-IND Dose Range Finding Studies for Lead Candidate EB-003, Targeting Neuropsychiatric Indications
Data establish maximum tolerated dose, supporting progression of lead neuroplastogen compound EB-003 toward IND-enabling studies and First-in-Human clinical trials Enveric Biosciences, Inc. (NASDAQ:ENVB) ("Enveric" or
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.